Today: 8 June 2026
Rivian stock slips again as UBS turns bearish — Wall Street tests the R2 and autonomy story
15 January 2026
1 min read

Rivian stock slips again as UBS turns bearish — Wall Street tests the R2 and autonomy story

New York, Jan 15, 2026, 10:47 AM EST — Regular session

  • Rivian shares edge lower in early Thursday trade after two analyst downgrades this week
  • Bears say autonomy and R2 optimism may be ahead of near-term results
  • Next earnings update is the nearest hard catalyst on the calendar

Shares of Rivian Automotive, Inc (NASDAQ: RIVN) fell about 1.1% to $17.32 in morning trade on Thursday, extending losses after a pair of analyst downgrades this week. The stock ended Wednesday down 7.2% at $17.50 and is still up about 44% over the past four months.

Wolfe Research analyst Emmanuel Rosner cut Rivian to sell, arguing it needs a stronger AI push — closer to Tesla’s playbook — if it wants to justify the valuation. He set a $16 price target and warned of a near-term “catalyst vacuum.” Barron’s

UBS followed with a downgrade to sell from neutral and a $15 price target, saying shares have climbed about 15% since the company’s Autonomy and AI Day in December and the rally was driven “more by sentiment than fundamentals.” UBS said point-to-point autonomy — where the car drives itself from start to finish — is not expected until the second half of 2026, with “eyes-off” functionality pushed to 2027. It also flagged tougher odds for licensing opportunities after Nvidia released an open-source autonomous model and Ford said it built its own Level 3 system in-house. Investing.com

On Wall Street, a price target is an analyst’s estimate of where a stock should trade over roughly the next year. A sell rating is shorthand for expecting the shares to lag peers, not a judgement on whether the product is compelling.

Rivian this week named Greg Revelle chief customer officer, putting him in charge of sales, marketing and operations ahead of the midsize R2 SUV launch. The company said first deliveries of the R2 are slated for the first half of 2026, while some new autonomy hardware is expected to reach the model toward the end of 2026. CEO RJ Scaringe said Revelle brings “deep experience across eCommerce, marketing and automotive,” and Revelle cited Rivian’s “commitment to AI and software-defined vehicles.” WardsAuto

For investors, the near-term problem is timing. Rivian has been trading like a software story, but the next real volume test still sits with the R2.

But the setup cuts both ways. A smooth R2 rollout, stronger demand than the banks model, or quicker progress turning driver-assist features into paid software could blunt the bear case; delays or cost surprises would do the opposite.

Rivian is due to report fourth-quarter and full-year 2025 results on Feb. 12 after market close. The company said it produced 10,974 vehicles and delivered 9,745 in the fourth quarter, and produced 42,284 and delivered 42,247 vehicles in 2025. Traders will watch cash burn, gross margin trends and any change to the R2 schedule.

Stock Market Today

  • Warren Buffett Highlights Communication as Key Skill for Career Success
    June 8, 2026, 2:58 AM EDT. Warren Buffett, who retired in 2025, emphasizes communication as a career multiplier, asserting clear expression unlocks potential often overlooked by schools. He overcame early stage fright using Dale Carnegie lessons and advises young professionals to refine their speaking and writing to ensure ideas spread effectively. Amazon's Jeff Bezos enforces written clarity through six-page memos, replacing slide decks to promote structured thinking and transparent decision-making. Buffett also stresses hiring individuals with intelligence, integrity, and energy, warning against expecting character change. His decades-long partnership with Charlie Munger exemplifies how shared values and clear communication drive sustained success. The practical lesson: master communication to make ideas understood and trusted, boosting career impact and leadership.

Latest articles

Snap Drops 5%—Ad Recovery Eyed Next

Snap Drops 5%—Ad Recovery Eyed Next

8 June 2026
Snap closed Friday at $5.76, down 5.11% amid a broad tech selloff triggered by a strong jobs report and renewed rate-hike worries, but still ended the week up 0.9%. Investors now await U.S. inflation data and CEO Evan Spiegel’s June 16 AWE keynote on Specs, as Snap faces pressure from weak North American ad revenue, tough competition, and activist demands for cost cuts.
Navitas’ Nvidia-Led Rally Stalls, Eyes on AI Trade Next Week

Navitas’ Nvidia-Led Rally Stalls, Eyes on AI Trade Next Week

8 June 2026
Navitas plunged $5.61 to $25.08 Friday as a $1.3 trillion chip selloff erased Nvidia-driven gains, despite news it issued 3.28 million shares for merger earn-outs and showcased its GaNFast power board at Nvidia’s AI MGX event; investors now face risks from share dilution, sector volatility, and Navitas’s early-stage pivot to high-power AI markets amid ongoing operating losses.
NIO Stock Drops Even as Deliveries Jump, Focus Turns to June Numbers

NIO Stock Drops Even as Deliveries Jump, Focus Turns to June Numbers

8 June 2026
NIO’s U.S.-listed shares plunged 5.8% Friday, erasing a delivery-led rally, as investors focus on whether June sales can hit the company’s Q2 target after May deliveries rose 62.3% to 37,705. NIO needs 42,939–47,939 June deliveries to meet guidance, with risks from China’s saturated car market and recent price pressure.
HPE Stock Faces AI Rally Test With Monday In Focus

HPE Stock Faces AI Rally Test With Monday In Focus

8 June 2026
Hewlett Packard Enterprise plunged 8.36% Friday to $49.20, capping a three-day slide and erasing gains after a post-earnings surge, even as it raised its fiscal 2026 revenue growth outlook to 29%-33% and boosted non-GAAP EPS guidance, with analysts warning that rapid gains may have priced in too much hope too quickly.
POET Technologies stock climbs before the bell as call-option volume spikes
Previous Story

POET Technologies stock climbs before the bell as call-option volume spikes

Philip Morris stock edges up after PMI flags $20B+ U.S. investment push, FDA ZYN review ahead
Next Story

Philip Morris stock edges up after PMI flags $20B+ U.S. investment push, FDA ZYN review ahead

Go toTop